Quirante, Ginalyn .
HRN: 24-42-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2025
METRONIDAZOLE 500MG (TAB)
05/25/2025
06/01/2025
PO
500mg
BID
SP Completion Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes